Plasma carboxy-terminal provasopressin (copeptin): A novel marker of insulin resistance and metabolic syndrome

Medicine & Life Sciences

• copeptins 100%
• Metabolic Syndrome 59%
• Insulin Resistance 52%
• African Americans 25%
• European Continental Ancestry Group 25%
• Arginine Vasopressin 21%
• Logistic Models 11%
• Odds Ratio 11%
• Diuretics 9%
• Hydroxymethylglutaryl-CoA Reductase Inhibitors 8%
• Vascular Diseases 8%
• HDL Cholesterol 8%
• Triglycerides 7%
• Fasting 7%
• Creatinine 7%
• Homeostasis 6%
• Smoking 6%
• Body Mass Index 6%
• Insulin 6%
• Health Care Outcome Assessment 6%
• Biomarkers 5%
• Exercise 5%
• Glucose 5%
• Education 5%
• Confidence Intervals 5%
• Serum 4%
• Therapeutics 1%

Chemical Compounds

• Insulin Derivative 65%
• Marker 56%
• Metabolic 52%
• Resistance 40%
• Plasma 39%
• White 23%
• High-Density Lipoprotein Cholesterol 14%
• Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor 13%
• Hypertensive 12%
• Diuretic 12%
• Creatinine 10%
• Triglyceride 9%
• Biological Marker 8%
• Glucose 6%